We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Allergan plc | NYSE:AGN | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 193.02 | 0 | 01:00:00 |
TIDM0QCV TIDM0Y7T FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Name of person dealing (Note 1) State Street Global Advisors & Affiliates --------------------------------------------- ------------------------------- Company dealt in AbbVie Inc. --------------------------------------------- ------------------------------- Class of relevant security to which US$0.01 common stock the dealings being disclosed relate (Note 2) --------------------------------------------- ------------------------------- Date of dealing 18(th) March 2020 --------------------------------------------- ------------------------------- 2. INTERESTS AND SHORT POSITIONS (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short ------------------------------------- -------------------- ----------- Number (%) Number (%) ------------------------------------- ---------- -------- ------ --- (1) Relevant securities 68,307,110 4.62574% ------------------------------------- ---------- -------- ------ --- (2) Derivatives (other than options) N/A ------------------------------------- ---------- -------- ------ --- (3) Options and agreements to purchase/sell N/A ------------------------------------- ---------- -------- ------ --- Total 68,307,110 4.62574% ------------------------------------- ---------- -------- ------ --- (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security: Long Short ------------------------------------------- ----------- ----------- Number (%) Number (%) ------------------------------------------- ------ --- ------ --- (1) Relevant securities N/A ------------------------------------------- ------ --- ------ --- (2) Derivatives (other than options) N/A ------------------------------------------- ------ --- ------ --- (3) Options and agreements to purchase/sell N/A ------------------------------------------- ------ --- ------ --- Total N/A ------------------------------------------- ------ --- ------ --- 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of relevant securities Price per unit (Note 5) -------------- ----------------------------- ----------------------- Purchase 300 71.03 -------------- ----------------------------- ----------------------- Purchase 8,300 69.69 -------------- ----------------------------- ----------------------- Purchase 2,700 71.03 -------------- ----------------------------- ----------------------- Purchase 1,600 71.03 -------------- ----------------------------- ----------------------- Purchase 3,900 71.03 -------------- ----------------------------- ----------------------- Purchase 6,700 71.03 -------------- ----------------------------- ----------------------- Purchase 3,400 71.03 -------------- ----------------------------- ----------------------- Purchase 900 71.03 -------------- ----------------------------- ----------------------- Purchase 107 65.36 -------------- ----------------------------- ----------------------- Purchase 3,874 71.03 -------------- ----------------------------- ----------------------- Purchase 16,002 71.03 -------------- ----------------------------- ----------------------- Purchase 256,921 71.03 -------------- ----------------------------- ----------------------- Purchase 15,960 71.03 -------------- ----------------------------- ----------------------- Purchase 17,955 71.03 -------------- ----------------------------- ----------------------- Purchase 812 71.03 -------------- ----------------------------- ----------------------- Purchase 194 71.03 -------------- ----------------------------- ----------------------- Purchase 16,956 71.03 -------------- ----------------------------- ----------------------- Purchase 735 71.03 -------------- ----------------------------- ----------------------- Purchase 90 71.03 -------------- ----------------------------- ----------------------- Purchase 1,100 68.16 -------------- ----------------------------- ----------------------- Purchase 300 71.03 -------------- ----------------------------- ----------------------- Purchase 500 71.03 -------------- ----------------------------- ----------------------- Purchase 700 71.03 -------------- ----------------------------- ----------------------- Purchase 1,000 71.03 -------------- ----------------------------- ----------------------- Purchase 706 71.03 -------------- ----------------------------- ----------------------- Purchase 807 71.03 -------------- ----------------------------- ----------------------- Purchase 563 71.03 -------------- ----------------------------- ----------------------- Sale 1,500 71.03 -------------- ----------------------------- ----------------------- Sale 300 71.03 -------------- ----------------------------- ----------------------- Sale 7,400 67.65 -------------- ----------------------------- ----------------------- Sale 1,900 71.03 -------------- ----------------------------- ----------------------- Sale 3,400 71.03 -------------- ----------------------------- ----------------------- Sale 300 71.03 -------------- ----------------------------- ----------------------- Sale 700 71.03 -------------- ----------------------------- ----------------------- Sale 1,600 71.03 -------------- ----------------------------- ----------------------- Sale 900 71.03 -------------- ----------------------------- ----------------------- Sale 100 65.55 -------------- ----------------------------- ----------------------- Sale 393 71.03 -------------- ----------------------------- ----------------------- Sale 606 71.03 -------------- ----------------------------- ----------------------- Sale 25,905 71.03 -------------- ----------------------------- ----------------------- Sale 18,945 71.03 -------------- ----------------------------- ----------------------- Sale 297 71.03 -------------- ----------------------------- ----------------------- Sale 706 71.03 -------------- ----------------------------- ----------------------- Sale 977 71.03 -------------- ----------------------------- ----------------------- Sale 977 71.03 -------------- ----------------------------- ----------------------- Sale 269 71.03 -------------- ----------------------------- ----------------------- Sale 1,600 66.70 -------------- ----------------------------- ----------------------- Sale 532 68.12 -------------- ----------------------------- ----------------------- (b) Derivatives transactions (other than options transactions) Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5) ------------- --------------------- ----------------------------- -------------- N/A ------------- --------------------- ----------------------------- -------------- (c) Options transactions in respect of existing relevant securities (i) Writing, selling, purchasing or varying Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money e.g. call option purchasing securities to which price American, date paid/received varying etc. the option relates European etc. per unit (Note 5) (Note 7) ----------------- ----------------- -------------------- -------- -------------- ------ ------------------ N/A ----------------- ----------------- -------------------- -------- -------------- ------ ------------------ (ii) Exercising Product name, Number of securities Exercise price per e.g. call option unit (Note 5) ----------------- -------------------- ------------------ N/A ----------------- -------------------- ------------------ (d) Other dealings (including transactions in respect of new securities) (Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) --------------------- ------- ------------------------- N/A --------------------- ------- ------------------------- 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. ----------------------------------------------------------- N/A ----------------------------------------------------------- Is a Supplemental Form 8 attached? (Note 9) NO ------------------------------------------------------- ----------------- Date of disclosure 19(th) March 2020 ------------------------------------------------------- ----------------- Contact name Lionel Colaco ------------------------------------------------------- ----------------- Telephone number 020 33956098 ------------------------------------------------------- ----------------- If a connected EFM, name of offeree/offeror with which N/A connected ------------------------------------------------------- ----------------- If a connected EFM, state nature of connection (Note N/A 10) ------------------------------------------------------- -----------------
(END) Dow Jones Newswires
March 19, 2020 11:00 ET (15:00 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Allergan Chart |
1 Month Allergan Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions